Spruce Biosciences, Inc. - Rasio total nilai perusahaan marang pendapatan SPRB

Spruce Biosciences (SPRB) - logo korporat

The prospects for Spruce Biosciences (SPRB) depend on the outcomes of late-stage trials and the approved pricing for rare pathology therapies. The enterprise value-to-sales multiple demonstrates valuation volatility, where the 0.00 level serves as a critical benchmark. The company's strategy relies on expanding the tildacerfont portfolio to capture market share, although the lack of commercial products creates a temporary capital deficit.

SPRB Spruce Biosciences, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

SPRB (Spruce Biosciences, Inc.): rincian analitis lan laporan miturut indikator

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Spruce Biosciences, Inc. SPRB
Produk asli sprucebiosciences.com

A conservative approach requires valuing Spruce Biosciences (SPRB) through the lens of actual cash generation, excluding the impact of leverage. This EV-to-sales ratio compares the total enterprise value with revenue, allowing for an assessment of the premium paid for Tildacerfont's patent protection and exclusive clinic access, which is critical for understanding the investment profile of this pharmaceutical ecosystem.

Pesaing langsung

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Pluristem Therapeutics PLUR|SYBX: Rasio nilai perusahaan marang pendapatan|lipocine.com - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan MTNB|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)